Abstract:Viral diseases are a major threat to modern society and the global health system. It is therefore of utter relevance to understand the way viruses affect the host as a basis to find new treatment solutions. The understanding of viral myocarditis (VMC) is incomplete and effective treatment options are lacking. This review will discuss the mechanism, effects, and treatment options of the most frequent myocarditis-causing viruses namely enteroviruses such as Coxsackievirus B3 (CVB3) and Parvovirus B19 (PVB19) on the human heart. Thereby, we focus on: 1. Viral entry: CVB3 use Coxsackievirus-Adenovirus-Receptor (CAR) and Decay Accelerating Factor (DAF) to enter cardiac myocytes while PVB19 use the receptor globoside (Gb4) to enter cardiac endothelial cells. 2. Immune system responses: The innate immune system mediated by activated cardiac toll-like receptors (TLRs) worsen inflammation in CVB3-infected mouse hearts. Different types of cells of the adaptive immune system are recruited to the site of inflammation that have either protective or adverse effects during VMC. 3. Autophagy: CVB3 evades autophagosomal degradation and misuses the autophasomal pathway for viral replication and release. 4. Viral replication sites: CVB3 promotes the formation of double membrane vesicles (DMVs), which it uses as replication sites. PVB19 uses the host cell nucleus as the replication site and uses the host cell DNA replication system. 5. Cell cycle manipulation: CVB3 attenuates the cell cycle at the G1/S phase, which promotes viral transcription and replication. PVB19 exerts cell cycle arrest in the S phase using its viral endonuclease activity. 6. Regulation of apoptosis: Enteroviruses prevent apoptosis during early stages of infection and promote cell death during later stages by using the viral proteases 2A and 3C, and viroporin 2B. PVB19 promotes apoptosis using the non-structural proteins NS1 and the 11 kDa protein. 7. Energy metabolism: Dysregulation of respiratory chain complex expression, activity and ROS production may be altered in CVB3- and PVB19-mediated myocarditis. 8. Ion channel modulation: CVB3-expression was indicated to alter calcium and potassium currents in Xenopus laevis oocytes and rodent cardiomyocytes. The phospholipase 2-like activity of PVB19 may alter several calcium, potassium and sodium channels. By understanding the general pathophysiological mechanisms of well-studied myocarditis-linked viruses, we might be provided with a guideline to handle other less-studied human viruses.

Mechanism of Dilated Cardiomyopathy Caused by Enterovirus Infection

[The Expression of Connexin 43 and Desmin in Viral Myocarditis].

Enterovirus Causing Progression of Heart Failure in a Patient with a History of Myocardial Infarction

Role of Coxsackievirus B3-Induced Immune Responses in the Transition from Myocarditis to Dilated Cardiomyopathy and Heart Failure

Virus-Host Interactions of Enteroviruses and Parvovirus B19 in Myocarditis

Vascular Endothelial Integrity Affects the Severity of Enterovirus-Mediated Cardiomyopathy

Expression and Significance of Coxsackie-Adenovirus Receptor in Myocardia With Dilated Cardiomyopathy

Abnormal expression of cytoskeletal proteins in patients with dilated cardiomyopathy

The Molecular Role of Immune Cells in Dilated Cardiomyopathy

Immune cells and related cytokines in dilated cardiomyopathy

Crosstalk Between Innate Immunity and Autophagy in Viral Myocarditis Leading to Dilated Cardiomyopathy

Local Immune Dysregulation and Subsequent Inflammatory Response Contribute to Pulmonary Edema Caused by Enterovirus Infection in Mice

Immunological mechanisms in myocarditis

Development of dilated cardiomyopathy with a long latent period followed by viral fulminant myocarditis: A case report

Identification of the communal pathogenesis and immune landscape between viral myocarditis and dilated cardiomyopathy

Acute enterovirus infections significantly alter host cellular DNA methylation status

Viral Dilated Cardiomyopathy with Heart Failure by CVB3 Inoculation in Balb/c Mice

Expression of CAR in Myocardial of Viral Myocarditis and Dilated Cardiomyopathy

Viral Myocarditis as a Factor Leading to the Development of Heart Failure Symptoms, Including the Role of Parvovirus B19 Infection—Systematic Review

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy in Vivo.

Neonatal Enterovirus-Associated Myocarditis in Dizygotic Twins: Myocardial Longitudinal Strain Pattern Analysis